Novel Requirements for Akt1 in T Cell Commitment
Novel Requirements for Akt1 in T Cell Commitment
批准号:
9246741
负责人:
Yina Hsing Huang
金额:
$45.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-15 至 2021-12-31
关键词:
1-Phosphatidylinositol 3-KinaseAblationAcute T Cell LeukemiaAdaptive Immune SystemAddressAffectAttentionAttenuatedB-LymphocytesBindingCD8B1 geneCell LineCell LineageCell SurvivalCell membraneCellsCouplesCytokine ReceptorsDefectDependencyDevelopmentDiseaseDoseES01EnsureFRAP1 geneFamilyFeedbackGene Expression RegulationGenerationsGenesGenetic TranscriptionHomologous ProteinHyperactive behaviorImmunologic Deficiency SyndromesInositolInvestigationKineticsLeadLigandsLipidsMalignant Epithelial CellMediatingMembraneMetabolicMetabolismModelingPDPK1 genePH DomainPTEN genePathologicPathway interactionsPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPolyphosphatesProtein IsoformsProtein-Serine-Threonine KinasesProteinsReadinessRecruitment ActivityRegulatory T-LymphocyteRoleSignal TransductionSurfaceT cell activating factorT cell regulationT cell transcription factor 1T-Cell DevelopmentT-Cell ReceptorT-LymphocyteThymocyte DevelopmentThymus GlandTimeTo specifyTranscriptTranscription CoactivatorTranscriptional Regulationalpha-beta T-Cell Receptorattenuationbeta catenincell growthcell typegene productglucose metabolismmembernotch proteinnovelprematureprogenitorreceptorthymocytetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Akt1, Akt2 and Akt3 are members of a family of serine/threonine kinases that are key effectors of PI3K. The
Akt family has been well characterized to promote cell survival, glucose metabolism and proliferation in
many cell types including developing T cells. Thymocytes express all Akt isoforms to varying degrees.
Ablation of single or multiple Akt genes results in differential blocks in T cell development. Loss of all three
Akt isoforms leads to an early developmental defect due to decreased survival of CD4–CD8– double
negative (DN) thymocytes. Expression of Akt2 or Akt3 alone is sufficient to preserve DN survival; however,
DN3 differentiation and DN4 thymocyte proliferation remain defective along with survival of cells at later
developmental stages. These distinct phenotypes suggest either that different Akt isoforms regulate distinct
functions or that different doses of Akt activity are required to promote stage-specific cell survival,
proliferation and differentiation. With no current evidence for isoform-specific functions, we focused our
attention on characterizing mechanisms for regulating the dose of Akt activity. Surface receptors, including
(pre-)T cell receptor and cytokine receptors, activate PI3K to generate PIP3. Interactions between PIP3 and
the Pleckstrin homology (PH) domain of Akt are required to recruit Akt to the plasma membrane for
activation. Thus, fine control of PI3K activity and PIP3 availability can directly regulate Akt activation levels.
This application addresses an increasingly important alternative mechanism for indirectly controlling Akt
activity: via generation of IP4, a soluble inositol polyphosphate that is structurally similar to PIP3. IP4 is
generated following (pre)TCR stimulation and competes with PIP3 for binding to the Akt PH domain.
Thymocytes deficient in IP4 activate Akt excessively following expression of preTCR at the DN3 and DN4
stages. Strikingly, Akt hyperactivity leads to accelerated β selection, premature reprogramming to glycolytic
metabolism and loss of Notch dependency. This leads us to propose the global hypotheses that 1) preTCR-
induced IP4 generation restricts Akt-dependent metabolic reprogramming and proliferation to ensure
adequate Notch signaling and 2) preTCR and Notch cooperative signaling is required for T cell lineage
specification. Successful completion of this study will shift our current understanding of T lineage
specification by revealing 1) an unexpected requirement for preTCR in imposing a Notch checkpoint and in
co-stimulating Notch function, 2) a novel preTCR feedback mechanism that controls DN thymocyte
proliferation/maturation via tuning of Akt activity and metabolic reprogramming; and 3) a non-canonical
pathway for activating TCF1-dependent transcription to specify T cell commitment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Activating Native Tumor Immunity with IL-33 Armored CARs
-
批准号:10744438
-
项目类别:
-
资助金额:$57.35万
-
财政年份:2023
-
负责人:Yina Hsing Huang
-
依托单位:
Sustaining Tissue Resident Memory T cells
-
批准号:10544791
-
项目类别:
-
资助金额:$52.68万
-
财政年份:2022
-
负责人:Yina Hsing Huang
-
依托单位:
Directing Cytokine Specificity Through Co-translational Carrier Coupling
-
批准号:10581947
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2022
-
负责人:Yina Hsing Huang
-
依托单位:
Sustaining Tissue Resident Memory T cells
-
批准号:10389592
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2022
-
负责人:Yina Hsing Huang
-
依托单位:
PH domains as Calmodulin binding domains
-
批准号:9023737
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2016
-
负责人:Yina Hsing Huang
-
依托单位:
PH domains as Calmodulin binding domains
-
批准号:9199208
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2016
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8225208
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8788798
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
Novel Requirements for Akt1 in T Cell Commitment
-
批准号:9405831
-
项目类别:
-
资助金额:$45.73万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
Novel Requirements for Akt1 in T Cell Commitment
-
批准号:10077817
-
项目类别:
-
资助金额:$45.73万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8108155
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8675320
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8602817
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLS
-
批准号:8416814
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2011
-
负责人:Yina Hsing Huang
-
依托单位:
Transcriptional cascades in the CD4/CD8 lineage choice
-
批准号:6445440
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2002
-
负责人:Yina Hsing Huang
-
依托单位:
海外基金